NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

末梢神经病变治疗的市场规模:类型,治疗(药物疗法,非药物疗法),各流通管道,各地区-尺寸,占有率,预测,及机会分析,2020年-2027年

Peripheral Neuropathy Treatment Market, by Type, by Treatment (Pharmacological Therapies and Non-pharmacological Therapies, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品编码 980048
出版日期 内容资讯 英文 205 Pages
商品交期: 2-3个工作天内
价格
末梢神经病变治疗的市场规模:类型,治疗(药物疗法,非药物疗法),各流通管道,各地区-尺寸,占有率,预测,及机会分析,2020年-2027年 Peripheral Neuropathy Treatment Market, by Type, by Treatment (Pharmacological Therapies and Non-pharmacological Therapies, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月31日内容资讯: 英文 205 Pages
简介

全球周围神经病治疗市场的增长因素包括人口老龄化增加。根据世界卫生组织(WHO)2018年2月发布的一篇文章,在2015年至2050年期间,世界老年人口比例将从12%几乎翻倍至22%。此外,糖尿病病例的增加有望推动市场的增长。根据国际糖尿病联盟(IDF)发表的一篇文章,2017年全球18-99岁糖尿病患者的估计人数约为4.25亿。

本报告提供全球末梢神经病变治疗市场的相关调查,提供市场规模和占有率,市场机会和趋势,成长及阻碍因素,类型·治疗·流通管道·各地区的市场分析,竞争情形,主要企业的简介等资讯。

目录

第1章 调查目的·前提条件

第2章 市场展望

  • 报告概要
    • 市场定义和范围
  • 摘要整理
    • 市场明细:各类型
    • 市场明细:不同治疗
    • 市场明细:各流通管道
    • 市场明细:各地区
  • Coherent Opportunity Map (COM)

第3章 市场动态,法规,及趋势分析

  • 市场动态
    • 成长要素
    • 阻碍因素
    • 市场机会
  • 影响分析
  • 开发平台分析
  • 偿付方案
  • 流行病学
  • PEST分析
  • 法规方案
  • 新产品的销售
  • 合作与契约
  • 市场趋势

第4章 COVID-19疫情的影响

  • COVID-19市场方案
  • COVID-19对末梢神经病变治疗药市场带来的影响

第5章 市场分析:各类型(2016-2027)

  • 简介
  • 糖尿病性末梢神经病变
  • 化疗诱发性末梢神经病变
  • 特发性末梢神经病变
  • 其他

第6章 市场分析:不同治疗(2016-2027)

  • 简介
  • 药物疗法
  • 非药物疗法

第7章 市场分析:各流通管道(2016-2027)

  • 简介
  • 医院和诊所
  • 门诊中心
  • 其他

第8章 市场分析:各地区(2016-2027)

  • 简介
  • 北美
  • 南美
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第9章 竞争情形

  • 热图分析
  • 市场占有率分析
    • Abbott
    • Bristol Myers Squibb
    • Cipla Limited
    • Eli Lilly and Company
    • GlaxoSmithKline plc.
    • Lupin Limited
    • Merck and Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Dr. Reddy's Laboratories
    • Mylan NV
    • Johnson & Johnson Services Inc.
    • Teva Pharmaceutical Industries Ltd.

第10章 分析师的见解

第11章 章节

目录

Title:
Peripheral Neuropathy Treatment Market, by Type (Diabetic Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy, Idiopathic Peripheral Neuropathy, and Others), by Treatment (Pharmacological Therapies (Pain Relievers, Anti-seizure Medications, and Antidepressants) and Non-pharmacological Therapies (Transcutaneous Electrical Nerve Stimulation, Plasma Exchange and Intravenous Immune Globulin, and Others), by Distribution Channel (Hospitals and Clinics, Ambulatory Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Peripheral neuropathy is a disorder that affects the peripheral nerves. Peripheral neuropathy has a variety of systemic, metabolic, and toxic causes, for instance diabetes in metabolic cause. The most common treatable causes include diabetes mellitus, hypothyroidism, and nutritional deficiencies. The diagnosis require careful clinical assessment, judicious laboratory testing, and electro diagnostic studies or nerve biopsy, if the diagnosis remains unclear.

Market Dynamics

Rising aging population is expected to drive the global peripheral neuropathy treatment market growth. For instance, according to an article published by the World Health Organization (WHO) in February 2018, reports that between 2015 and 2050, the proportion of the worldwide geriatric population will nearly double from 12% to 22%.

Moreover, rising diabetic cases is expected to drive the market growth. For instance, according to an article published by the International Diabetes Federation (IDF), in 2017, the estimated number of 18 to 99 year old diabetic patients was around 425 million globally.

researched

medicinal properties of cannabis and its derivatives are widely

Researched

Medicinal properties of cannabis and its derivatives are widely

researched

medicinal properties of cannabis and its derivatives are widely

researched

medicinal properties of cannabis and its derivatives are widely

researched

Key features of the study:

  • This report provides in-depth analysis of the global peripheral neuropathy treatment market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global peripheral neuropathy treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study are Abbott, Bristol Myers Squibb, Cipla Limited, Eli Lilly and Company, GlaxoSmithKline plc., Lupin Limited, Merck and Co. Inc., Novartis AG, Pfizer Inc., Dr. Reddy's Laboratories, Mylan NV, Johnson & Johnson Services Inc., and Teva Pharmaceutical Industries Ltd, among others.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
  • The global peripheral neuropathy treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global peripheral neuropathy treatment market.

Detailed Segmentation:

  • Global Peripheral Neuropathy Treatment Market, By Type:
    • Diabetic Peripheral Neuropathy
    • Chemotherapy-induced Peripheral Neuropathy
    • Idiopathic Peripheral Neuropathy
    • Others
  • Global Peripheral Neuropathy Treatment Market, By Treatment:
    • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
    • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
  • Global Peripheral Neuropathy Treatment Market, By Distribution Channel:
    • Hospitals and Clinics
    • Ambulatory Centers
    • Others
  • Global Peripheral Neuropathy Treatment Market, By Region:
    • North America
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Type:
      • Diabetic Peripheral Neuropathy
      • Chemotherapy-induced Peripheral Neuropathy
      • Idiopathic Peripheral Neuropathy
      • Others
      • By Treatment:
      • Pharmacological Therapies
      • Pain Relievers
      • Anti-seizure Medications
      • Antidepressants
      • Non-pharmacological Therapies
      • Transcutaneous Electrical Nerve Stimulation
      • Plasma Exchange and Intravenous Immune Globulin
      • Others
      • By Distribution Channel:
      • Hospitals and Clinics
      • Ambulatory Centers
      • Others
      • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Abbott*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Bristol Myers Squibb
    • Cipla Limited
    • Eli Lilly and Company
    • GlaxoSmithKline plc.
    • Lupin Limited
    • Merck and Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Dr. Reddy's Laboratories
    • Mylan NV
    • Johnson & Johnson Services Inc.
    • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Treatment
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Pipeline Analysis
  • Reimbursement Scenario
  • Epidemiology
  • Pest Analysis
  • Regulatory Scenario
  • New Product Launches
  • Collaborations and Agreements
  • Market Trends

4. Global Peripheral Neuropathy Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Market Scenario
  • Impact of COVID-19 Market on the Peripheral Neuropathy Treatment Products

5. Global Peripheral Neuropathy Treatment Market, By Type, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Diabetic Peripheral Neuropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Chemotherapy-induced Peripheral Neuropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Idiopathic Peripheral Neuropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Peripheral Neuropathy Treatment Market, By Treatment, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Pharmacological Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Pain Relievers
    • Anti-seizure Medications
    • Antidepressants
  • Non-pharmacological Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Transcutaneous Electrical Nerve Stimulation
    • Plasma Exchange and Intravenous Immune Globulin
    • Others

7. Global Peripheral Neuropathy Treatment Market, By Distribution Channel, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Ambulatory Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

8. Global Peripheral Neuropathy Treatment Market, By Region, 2016 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2027
  • North America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
    • Abbott
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Bristol Myers Squibb
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Cipla Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • GlaxoSmithKline plc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Lupin Limited
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck and Co. Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Dr. Reddy's Laboratories
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Mylan NV
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Johnson & Johnson Services Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

10. Analyst Views

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact